Crespo et al. (2024) reported that interactions between PP2A, its regulators, such as the immediate early response family genes, and PP2A target proteins may influence tumorigenesis in aggressive prostate cancer, in which these regulators are often upregulated [106]. The gene discussed is PTPA; the disease is prostate cancer.